skip to content

Media

Stay up-to-date with Roche's latest news, events and announcements.

Media events

Never miss out on past and upcoming Roche events

Media statements

Get access to the latest Roche media statements

Subscribe to Roche news

Get the latest news and updates to your inbox

24 million

patients were treated with Roche medicines in 2024

30 billion

Roche Diagnostics test were delivered to customers worldwide in 2024

+1%

Core investments in research and development in 2024: CHF 13.2 billion

Our two divisions are focusing jointly on three disease areas that will account for almost 50% of the global disease burden by 2035: cancer, cardiovascular-metabolic diseases and neurological diseases.

Portrait of Thomas Schinecker

Dr Thomas Schinecker

CEO Roche Group

Roche’s First Quarter Sales 2025

Roche has published its First Quarter Sales for 2025 prior to the opening of the Swiss Stock Exchange on Thursday, 24th April 2025.

Learn more

A blue-gloved hand delicately holds a small pink container with a QR code. Nearby are green, blue, and yellow containers on a white surface, indicating a scientific setting.

Roche’s Annual Report 2024

Discover how we're revolutionalising patient care in our 2024 Annual Report. Focused on innovation, research, sustainability, and strategic partnerships, with insights into our groundbreaking approaches.

Learn more

Microscopic image showing glowing blue cells clustered amidst intricate golden brown network, emitting a vibrant and scientific atmosphere.

Media contacts

Do you need to get in touch with us? Reach out to our media team with your enquiries.

In the spotlight

See all stories